• Home
  • Topics
    • Health Insurance Coverage
    • Medicare
    • Medicaid and CHIP
    • Blue Cross Blue Shield
    • Health Insurance Companies
    • Prescription Drugs and Pharmacy
    • Healthcare Policy and Law
    • Hospitals and Health Systems
    • Healthcare Business
    • Health Technology and AI
    • Senior Care
    • Public Health and Research
  • Guides
    • All Health Insurance Guides
    • Choosing a Health Insurance Plan
    • Individual Health Insurance
    • Family Health Insurance
    • High Deductible Health Plans
    • Short-Term Health Insurance
    • Self-Employed Health Insurance
    • Student Health Insurance
    • Low Income Health Insurance
    • Health Sharing Plans
  • Insurance Company List
  • About Us

Health Plan News

Timely Health Plan News and Commentary

Health Plan News
Home Archives for Healthcare Business

Healthcare Business News

The business of health care moves through deals, earnings, funding rounds and leadership changes. This section of Health Plan News covers the corporate side of the industry across insurers, providers, pharmacy companies and health services vendors.

What We Cover

We report on mergers and acquisitions, divestitures, quarterly and annual financial results, bankruptcies and restructurings, venture capital and private equity investment in health care companies, initial public offerings (IPOs), strategic partnerships, major contract awards, and executive and board appointments. Where a transaction affects members or patients, such as a carrier selling a business line or a provider group joining a larger system, we explain what changes and what does not.

Why Business News Matters to Health Plan Members

Consolidation shapes the market. When insurers acquire provider groups, when health systems merge, or when a pharmacy benefit manager is bought by a carrier, the result can change networks, pricing and access to care. Financial results also signal where carriers are expanding and where they are pulling back, which often foreshadows the plan changes announced during open enrollment.

Business news is linked closely with our other sections. Carrier earnings and strategy appear alongside Health Insurance Companies and Blue Cross Blue Shield coverage. Provider transactions connect to Hospitals and Health Systems. Funding for digital health and artificial intelligence (AI) startups connects to Health Technology and AI, and antitrust review of large deals appears in Healthcare Policy and Law.

The latest healthcare business news appears below, newest first.

Stellar Biotechnologies anuncia marco de cooperação com a Bayer Innovation

Posted on September 13, 2010 Written by Editor

BYRB).

Um marco essencial para a viabilidade do projeto foi alcançado com o “Acordo de Desenvolvimento Conjunto”. Sob os termos do acordo, a Stellar Biotechnologies fornece o Keyhole Limpet Hemocyanin (KLH) que é acoplado com a proteína idiotipo produzida pelas plantas de tabaco. O KLH é uma proteína imunoestimulante altamente potente, que faz com que os linfócitos pensem que até mesmo as proteínas mais familiares sejam consideradas estranhas. Durante a resposta imunológica que ocorre, os linfócitos se concentram principalmente na sequência de peptídeo do idiotipo anexado ao tumor. Esta molécula transportadora chamada de imunogênica tem origem exclusivamente da rara hemocianina do caramujo Megathura crenulata, e a Stellar possui a tecnologia para a manutenção do animal, a extração não-letal da molécula crítica e um processo de refinamento lucrativo da KLH.

Com o consentimento das duas partes, a Stellar receberá um pagamento marco da BIG, e o acordo de co-desenvolvimento está sendo ampliado e continua a alcançar marcos de pontos finais importantes que podem ser essenciais para os interesses da Bayer nas vacinas terapêuticas baseado no seu sistema de expressão de proteína de plantas, a tecnologia magnICON(R).

O Dr. John Butler, Líder do Projeto Global de Produtos Farmacêuticos de Plantas (PMP) da Bayer, disse: “Estamos contentes em atingir este marco importante e apreciamos o trabalho que fizemos com a equipe científica de talento da Stellar, liderado pelo Professor Daniel Morse. Juntamente com os cientistas e engenheiros da Bayer, acreditamos que tivemos um impacto substancial na estrutura de custo potencial e na eficácia e sustentabilidade da produção da nossa vacina. A garantia de um fornecimento sustentável de KLH a longo prazo é um elemento-chave do nosso trabalho de habilitar uma nova terapia que possa beneficiar significantemente os resultados da doença e a qualidade de vida dos pacientes NHL”.

Frank Oakes, CEO da Stellar, disse: “A Stellar foi honrada com a oportunidade desta parceria com a equipe de ponta da Bayer Innovation, e agora, de levar este novo relacionamento para o próximo nível. A Bayer Innovation é uma das participantes mais consideradas da área PMP, e acreditamos que a credibilidade vem do nosso trabalho com as grandes empresas internacionais de biotecnologia, ciências de materiais e produtos farmacêuticos. Estamos empolgados com a oportunidade de ampliar este relacionamento, e o potencial de explorar oportunidades de desenvolvimento de negócios futuros com a Bayer Innovation”.

Bayer Innovation GmbH (BIG — http://www.bayer-innovation.com/en/homepage.aspx) faz parte da estratégia de inovação da Bayer e complementa as atividades de inovação de diferentes subgrupos das áreas de cuidado da saúde, nutrição e materiais de alta qualidade. O seu objetivo é identificar e desenvolver novas oportunidades de crescimento, preparando a entrada em mercados novos e em expansão. Atualmente ela está concentrada na tecnologia médica e na produção de produtos farmacêuticos feitos de planta.

Stellar Biotechnologies, Inc. (TSX-V: KLH) (PINKSHEETS: SBOTF) (www.StellarBiotechnologies.com) é líder mundial de manufatura sustentável de proteínas transportadoras de imunidade (ICP), principalmente em relação à proteína farmacêutica mais importante da sua classe, KLH (Keyhole Limpet Hemocyanin). Esta proteína antiga evolutiva tem uma estrutura altamente complexa, tornando-a ideal para uso em vacinas de uso humano e animal, e produtos de diagnóstico. Com parceiros e clientes, seus produtos KLH principais da Stellar estão na clínica e a caminho de se tornar a única fonte farmacêutica de longo termo sustentável.

As declarações deste press release, além da informação de fatos puramente históricos, incluindo as declarações com relação a receita ou lucros, ou os planos e objetivos futuros da Empresa, ou vendas previstas, fluxo de caixa e gastos de capital, constituem declarações de previsão. As declarações de previsão são baseadas em várias suposições e estão sujeitas a todos os riscos e incertezas inerentes aos negócios da Empresa, incluindo os riscos inerentes à história da tecnologia. Não há nenhuma garantia de que tais declarações de previsão sejam corretas, pois os resultados e eventos atuais e futuros podem ser substancialmente diferentes dos resultados previstos por tais declarações. Por isso, os leitores não devem contar muito com tais declarações. Com exceção das leis de títulos mobiliários, a Empresa rejeita qualquer obrigação de atualizar tais declarações de previsão ou declarações de previsão que estão incorporadas a este documento por referência. Este press release não é uma oferta de venda nem uma solicitação de oferta de compra de quaisquer títulos mobiliários da Empresa dos EUA, ou para o benefício ou em nome de uma pessoa americana ou dos EUA. Nem a TSX Venture Exchange nem a sua Regulation Services Provider (de acordo com o termo definido nas políticas da TSX Venture Exchange) são responsáveis pela adequação ou correção deste release.

Filed Under: Healthcare Business

TRDX Announces Completion of Key Milestone and Provides Details on Closing of Definitive Agreement With Genesis Biopharma, Inc.

Posted on September 10, 2010 Written by Editor

SOURCE: Trend Exploration, Inc.

JERICHO, NY–(Marketwire – September 10, 2010) –  SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. (“TRDX” or the “Company”) (PINKSHEETS: TRDX) today confirms it has completed the structuring of DiabetRX Pharma Corp. (“DiabetRX”) which will be assigned the Sublicense and upon Final Closing will be 100% owned by TRDX.

In addition, the Company provides the following details regarding the recently executed Definitive Sublicense Agreement (“Definitive”) with Montreal-based Genesis Biopharma, Inc. (“Genesis”).

Dr. Jan Stahl, CEO of TRDX, commented: “Since the signing of the Definitive Agreement, I am very happy with the progress we have made with Genesis. We feel confident in the current steps we are taking to complete the Initial Closing and first Tranche financing. We view DiabetRX as a long term investment with large potential and look forward to the Final Closing.”

About Genesis Biopharma, Inc.

Genesis Biopharma, Inc. (www.genesisbiopharma.com) is a Canadian corporation founded in 2007 to exploit the commercial potential for the therapeutic use of peptidomimetic (modified amino acid peptides) compounds. Amino acids are the building blocks of proteins, which are found in every cell. Proteins consist of extremely long and complex amino acid chains. In contrast, a peptide is a short string of amino acids, joined by chemical bonds (also called “amide bonds”).

About SCIMEDENT f/k/a Trend Exploration, Inc. (PINKSHEETS: TRDX)

SciMeDent is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.

Cautionary Statement Regarding Forward-Looking Statements

A number of statements contained in this press release are forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the sufficiency of existing capital resources, technological or industry changes and uncertainties related to the development of the Company’s business model. The actual results the Company may achieve could differ materially from any forward-looking statements due to such risks and uncertainties.

Contact:
SciMeDent Health Corp. f/k/a Trend Exploration, Inc.
[email protected]
1-866-383-1374

Filed Under: Healthcare Business

MMRGlobal Launches New Travel and Benefits Sales Group

Posted on September 10, 2010 Written by Editor

SOURCE: MMRGlobal, Inc.

Company Sees Untapped Markets for Personal Health Records

LOS ANGELES, CA–(Marketwire – September 10, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF) (www.mmrglobal.com) announced today the formal launching of a new department, MMRGlobal Travel and Benefits Sales Group. The group will be headed by Patrice A. Shilling, newly named Vice President, Global Travel and Benefit Sales. Shilling is an experienced travel executive who has worked in senior management positions at Travelocity Business, American Express, Alitalia Airlines and Le Méridien and whose clients have included Samsung, McKesson, Medtronic, Accenture, UBS, Boston Scientific and Liberty Mutual, amongst numerous other Fortune 500 and 1000 companies.

Robert H. Lorsch, MMRGlobal Chairman and CEO, said, “Patrice Shilling will lead an initiative to sell our branded Personal Health Record (PHR) (www.mmrvideos.com) and MyEsafeDepositBox products to travel procurement groups and employers with the emphasis on how they add to the safety and security of employees who travel globally, particularly expats. Our strategy will also include targeting organizations like ADP who work regularly with human resources executives and corporate purchasing departments.”

Shilling said, “Our plan envisions selling through corporate procurement, human resources and risk management, as these are untapped channels. Opportunity exists to establish strategic partnerships and alliances with online technology companies, including associations, financial and affinity groups, reward programs and travel providers such as my previous employers American Express and Travelocity Business.”

About MMRGlobal, Inc.
MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward-Looking Statements
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of such terms and other comparable terminology. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.’s business prospects, results of operations or financial condition, government regulation, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

Contact:

Bobbie Volman
MMRGlobal, Inc.
(310) 476-7002
[email protected]

Michael Selsman
Public Communications Co.
(310) 553-5732
[email protected]

Click here to see all recent news from this company

Filed Under: Healthcare Business

TomoTherapy to Present at Baird’s 2010 Health Care Conference

Posted on September 10, 2010 Written by Editor

SOURCE: TomoTherapy

MADISON, WI–(Marketwire – September 10, 2010) –  TomoTherapy Incorporated (NASDAQ: TOMO), maker of advanced radiation therapy solutions for cancer care, today announced that CFO Thomas Powell and Vice President of Operations and Business Development Eric Schloesser will present at Baird’s 2010 Health Care Conference on Wednesday, September 15, 2010 at 11:00 a.m. ET. The conference will be held at the St. Regis New York Hotel in New York City, N.Y.

A live audio Webcast of the presentation will be available on the investor relations page of TomoTherapy.com. For those who are unable to listen to the live presentation, an archive of the Webcast will be available on the company’s site for 30 days following the presentation.

About TomoTherapy Incorporated 
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.

©2010 TomoTherapy Incorporated. All rights reserved. TomoTherapy, Tomo, TomoDirect, TQA, the TomoTherapy logo and Hi·Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.

Filed Under: Healthcare Business

Vigil Health Solutions Announces Share Consolidation

Posted on September 9, 2010 Written by Editor

VICTORIA, BRITISH COLUMBIA–(Marketwire – Sept. 9, 2010) – Vigil Health Solutions Inc. (“Vigil”) (TSX VENTURE:VGL)today announced that, effective the opening of trading on September 10, 2010, Vigil’s common shares will be consolidated on the basis of one post-consolidation common share for each twenty pre-consolidation common shares. The consolidation was approved at Vigil’s Annual General and Special Meeting of shareholders held on August 24, 2010. Vigil currently has 100,046,135 pre-consolidation common shares outstanding. Vigil will have approximately 5,002,310 post-consolidation common shares outstanding. Vigil’s name and trading symbol on the TSX Venture Exchange will not be changed in connection with the consolidation.

Filed Under: Healthcare Business

Emerging Multi-Talented Rocker Graham Czach — Nominated for The Deli Chicago’s Artist of the Month — Teams With Planned Parenthood of Illinois at…

Posted on September 9, 2010 Written by Editor

SOURCE: Graham Czach

CHICAGO, IL–(Marketwire – September 8, 2010) –  Graham Czach‘s wild creativity and unique versatile sound have earned the Windy City native a nomination for The Deli Chicago’s Artist of the Month. Fans can vote online through September 15 by clicking http://chicago.thedelimagazine.com/snacks.

The socially conscious rocker (www.grahamczach.com) is also teaming up with Planned Parenthood of Illinois (PPIL) to celebrate the official release of his independent debut album Lucid on Friday, October 15 at Martyrs (3855 North Lincoln Ave.) in Chicago. The show begins at 9:30 p.m. Tickets are $12 and may be purchased at www.martyrslive.com or at the door.

With a Chicago Music Award under his belt, the versatile singer/songwriter and multi-instrumentalist will bring his modern and progressive rock sensibilities to life performing with the album’s original band members: drummer Kris Myers (Umphrey’s McGee), keyboardist Matt Nelson (Lupe Fiasco, Matthew Santos), guitarist Chris Siebold (Howard Levy, Kick the Cat) and bassist Graham Burris (Lupe Fiasco, Matthew Santos).

Czach — whose album includes a powerful song about abortion rights titled “Choice” — is donating a portion of sales generated from the event to PPIL. PPIL’s 17 health centers throughout the state deliver comprehensive reproductive health care services, sex education, and sexual health information to more than 60,000 women, men, and teens each year.

In addition to Planned Parenthood of Illinois, a portion of the proceeds from Lucid is being donated to other non-profit organizations including Greenpeace, the American Cancer Society and the Art of Living Foundation.

As Lucid sheds light on these important social issues and more, Czach draws on a fascinating, diverse musical background — which includes his work with Chicago Afrobeat Project — to create musical landscapes as compelling as the lyrics. He was recently interviewed by Skope Magazine‘s editor Mike Friedman and by Lisa Smith of The Blend Magazine for their Take Action Party surrounding his earth-friendly messages.

Tapping into his childhood where Led Zeppelin, The Beatles and Crosby, Stills, Nash & Young were practically a religion, and later influences like Pink Floyd, Red Hot Chili Peppers, The Mars Volta and Jimi Hendrix, he infuses hard rocking, sometimes unusually metered grooves to four (and more) part vocal harmonies, beautiful acoustic melodies and vibrant unfolding string arrangements.

Contact:
Chrissy Sutphin
(818) 760-8077

Click here to see all recent news from this company

Filed Under: Healthcare Business

Medline’s Dubuque, Iowa State-of-the-Art Service Facility Awarded Silver LEED Certification

Posted on September 8, 2010 Written by Editor

SOURCE: Medline Industries, Inc.

The 66,000 Square-Foot Facility Receives Silver Certification From LEED for Its Green Impacts on the Environment

MUNDELEIN, IL–(Marketwire – September 8, 2010) –  A little over a year after Medline Industries, Inc., the largest privately held manufacturer and distributor of healthcare supplies in the U.S., completed and opened its new environmentally conscious service facility center in Dubuque, Iowa, the building officially received Leadership in Energy and Environmental Design (LEED) silver certification.

LEED is an internationally recognized, third party validation system of certification for many buildings. It measures and evaluates design, construction, operation and maintenance solutions. LEED is generally viewed as a trusted benchmark for a building’s impact on the environment.

In order to receive this certification, Medline applied and the building was then evaluated by LEED, who allocated points based on preset green criteria — focusing on energy efficiency and CO2 reduction. There are seven areas on which LEED evaluated the service facility: sustainability of the site, water efficiency, energy and atmosphere, materials and resources, indoor environmental quality, location and linkages, awareness and education, innovation in design and regional priority. To achieve silver certification, the second highest certification category, the service facility was awarded points that placed them in the 60-79 point range out of a 100-base point system. 

“The building was constructed with the environment and LEED certification in mind,” said Robert Abrams, the Corporate Director who oversaw the project. “Some of the green aspects of the 66,000-square-foot facility are daylight harvesting energy-efficient lighting, solar-tracking skylights, technologically advanced building insulation materials, tankless hot water heaters and a geothermal heating system.”

The installation of these and other green technologies resulted in an electrical use reduction of 320,565 kWh, which avoids more than 230 metric tons of carbon dioxide. This is equivalent to removing the CO2 emissions from 26,131 gallons of gasoline consumed or 535 barrels of oil consumed. All of this gathered points for certification as well as small things, such as close parking for a Prius, cubical walls made with recycled fabric that traveled less than 500 miles from their manufacturer and energy efficient trash management. 

“I think it demonstrates Medline’s commitment to the environment as a company, and it was important for our customers,” Abrams said. “We’re being asked more and more what we’re doing to reduce our carbon footprint.”

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Media Contacts:
Jerreau Beaudoin
(847) 643-3011

John Marks
(847) 643-3309

Filed Under: Healthcare Business

Coventry Health Care to Speak at the Morgan Stanley Global Healthcare Conference

Posted on September 8, 2010 Written by Editor

SOURCE: Coventry Health Care, Inc.

BETHESDA, MD–(Marketwire – September 8, 2010) –  Coventry Health Care, Inc. (NYSE: CVH) announced today that John Stelben, Interim Chief Financial Officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York, New York, at 1:00 p.m. ET on Monday, September 13, 2010. 

The public may access a live webcast of the presentation on the Investor Relations page of Coventry’s website at www.coventryhealthcare.com. A replay of the presentation will be available at the same website following the presentation until Monday, September 20, 2010.

Coventry Health Care (www.coventryhealthcare.com) is a diversified national managed healthcare company based in Bethesda, Maryland, operating health plans, insurance companies, network rental and workers’ compensation services companies. Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators.

Contact:
Drew Asher
SVP, Corporate Finance
(301) 581-5717

Filed Under: Healthcare Business

CEGEDIM : Acquisition of French company Deskom

Posted on September 8, 2010 Written by Editor

SOURCE: CEGEDIM

BOULOGNE-BILLANCOURT, FRANCE–(Marketwire – September 8, 2010) – Cegedim: acquisition of French
company Deskom

Deal allows Cegedim to strengthen its positions in the European invoice
dematerialization market

Paris, September 8, 2010 – Cegedim, a global technology and services
company specializing in the healthcare field, announces the acquisition of
Deskom, a leading French B-to-B invoice dematerialization company. The deal
is an opportunity for Cegedim EDI, its professional electronic data
management department, to build on its leadership in the field.

The Deskom acquisition allows Cegedim EDI, the healthcare data exchange
leader, to move ahead with its strategy of opening its services to all
business sectors and becoming Europe’s top electronic invoicing network,
able to handle any request regardless of invoice volumes, project
complexity, or the number of countries involved.

Created in 2004, Deskom markets a complete range of e-invoicing services,
from invoice digitization and publishing to tax dematerialization and legal
archiving. It has more than 2,000 clients in a wide range of industrial and
service fields: transport, energy, manufacturing, distribution, retail,
automobiles, banking/insurance and services. With a dynamic structure built
on a human scale, Deskom has been experiencing robust revenue growth since
2006.

After ushering Deskom through a robust growth phase, the company’s
shareholders – the Galileo and 123Venture investment funds – have chosen to
pass the torch to Cegedim, an industry shareholder with the know-how to
unlock Deskom’s significant potential.

The first company in France to offer e-invoices authorized by the Direction
Générale des Impôts tax authority in 1992, Cegedim
successfully launched its Global Invoice Services offering in 2005,
available in SAAS delivery. Since then, the company has carried out more
than 150 large-scale dematerialization projects involving close to 50,000
partners in France and in Europe.

“In a rapidly growing market buoyed by companies’ desire to optimize their
processes, cut costs and reduce their environmental impact, this
acquisition gives us the opportunity to put together a comprehensive
offering without precedent with respect to the range of functions and the
staff expertise and resources needed to successfully execute client
projects in France and abroad,” says Arnaud Guyon, Head of Cegedim Group
dematerialization activities.

“The market needs well-established electronic data exchange specialists
with the critical size needed to handle invoice dematerialization and
archiving operations. By joining the Cegedim Group, Deskom is securing its
future and strengthening its position to help its clients and improve its
prospects. It is also an opportunity to expand its service offering to all
types of electronic messages. This link-up will also allow us to create
Europe’s top multi-sector e-invoicing network,” says Cyrille Sautereau,
Director of Deskom.

The deal was finalized on September 6, 2010 by internal financing. These
activities represent annual revenues of around 4 million euros and will be
part of the consolidation scope of Cegedim Group for H2 2010.

About Cegedim EDI and Global Invoice Services: Cegedim EDI is the
department of Cegedim Group specializing in electronic data interchange.
Initially focused on the healthcare sector, the business now caters to a
wide range of sectors like mass-market retail, automobiles, transportation,
and so on. Its Global Invoice Services (GIS) platform permits the
connection and exchange of invoices between suppliers and clients equipped
with heterogeneous information systems. Totally compliant with current EU
laws, Global Invoice Services makes it possible for users to manage all
functional, technical and legal aspects of electronic invoicing, archiving
and restitution. For more information: www.cegedim-demat.com and
www.global-invoice-services.com

About Cegedim: Founded in 1969, Cegedim is a global technology and services
company specializing in the healthcare field. Cegedim supplies services,
technological tools, specialized software, data flow management services
and databases. Its offerings are targeted notably at healthcare industries,
life sciences companies, healthcare professionals and insurance companies.
The world leader in life sciences CRM, Cegedim is also one of the leading
suppliers of strategic healthcare industry data. Cegedim employs 8,600
people in more than 80 countries and generated revenue of ?874 million
in 2009. Cegedim SA is listed in Paris (EURONEXT: CGM). To learn more,
please visit: www.cegedim.com

This information is provided by HUGIN

Filed Under: Healthcare Business

New Preschool and Recreational Facility Responds to Growing Need for Calgary Childcare Services

Posted on September 8, 2010 Written by Editor

CALGARY, ALBERTA–(Marketwire – Sept. 8, 2010) – Today, Brite Studios (Brite), a centre for learning, activity and family engagement, announced the launch of their new name and location. Formerly known as Calgary Children’s Centre, Brite is a preschool and recreational facility providing unique programs to children of all ages.

The Honourable Ron Liepert and Alderman Joe Connelly were in attendance at the event to launch innovative childcare programs at the new location and to show their support for the facility. “We’re thrilled to be celebrating the opening of our new location, and our new name speaks to the facility’s collaborative nature,” said Lisa Davis, Founder and CEO of Brite Studios. “Brite provides families with a wide range of options for childcare, and gives kids the opportunity to grow and develop in an environment that keeps their imaginations stimulated. The community has been very welcoming and we look forward to the exciting new initiatives at Brite Studios.”

The opening took place at Brite’s new location in southwest Calgary. The launch included a creative ribbon cutting ceremony as well as a performance by some of the children that attend Brite. The new facility responds to the need for more specialized childcare in the community.

Due to high rent prices for commercial real estate, most preschools are located in church basements and community centres. With a combination of preschool and recreational programs, Brite has found an innovative way to sustain a commercial location.

Brite offers the highest quality programs available. “When developing our curriculum, we use only the most effective teaching methods and are one of the few preschools to use Reggio Emilia techniques” said Davis. “Our approach emphasizes creative learning and ensures that each child receives an education well-suited to their needs, interests and abilities.”

Brite is unique in that it offers both half and full day preschool services as well as recreational classes. With advisement of experts in the field of youth education, Brite employs the most progressive programs and teaching methods. The facility offers a range of creative programs for children, as well as adult classes.

For more information on Brite Studios please visit www.britestudios.ca.

About Brite Studios

Brite Studios, formerly known as Calgary Children’s Centre, is a preschool and recreational facility. Brite provides both half and full day preschool programs, as well as a wide range of recreational programs for children and adults. Programs include princess dance class, kid karate, vocal lessons, art classes and yoga. Brite is known for their enthusiasm and creativity in the development of curriculum. For more information please visit www.britestudios.ca.

Filed Under: Healthcare Business

CONMED Corporation Will Participate in Upcoming Investor Conferences

Posted on September 7, 2010 Written by Editor

SOURCE: CONMED Corporation

UTICA, NY–(Marketwire – September 7, 2010) –  CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for surgical and patient monitoring markets, announced today that the Company will participate in three investor conferences during the second week of September 2010 as follows:

  • Morgan Stanley Global Healthcare Conference on September 14, 2010 at 3:20 PM Eastern, in New York City

  • CL King Best Ideas Conference on September 15, 2010 at 2:45 PM Eastern, in New York City

  • Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 at 2:40 PM Eastern, in Boston

Mr. Joseph J. Corasanti, President and CEO of CONMED, will discuss the Company’s business. The live webcasts of CONMED’s presentations will be available at www.conmed.com in the Investor Relations – Events Calendar section of the website and will be available for replay through September 24, 2010.

CONMED Profile

CONMED is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and patient monitoring. The Company’s products serve the clinical areas of sports medicine-arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery and endoscopic technologies. Surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology use the Company’s medical devices. Headquartered in Utica, New York, the Company’s 3,300 employees distribute its products worldwide from several manufacturing locations.

Forward Looking Information

Certain statements made in the presentations may constitute forward-looking statements. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. They will be based upon management’s expectations and involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements therein or in previous disclosures. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. In addition to general industry and economic conditions, factors that could cause actual results to differ materially from those discussed in the forward-looking statements include, but are not limited to: (i) the failure of any one or more of management’s assumptions to prove to be correct; (ii) the risks relating to forward-looking statements discussed in the Company’s filings with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and Quarterly Reports on Form 10-Q; (iii) cyclical purchasing patterns from customers, end-users and dealers; (iv) timely release of new products, and acceptance of such new products by the market; (v) the introduction of new products by competitors and other competitive responses; (vi) the possibility that any new acquisition (and its integration) or other transaction may require the Company to reconsider its financial assumptions and goals/targets; (vii) increasing costs for raw material, transportation, or litigation; and/or (viii) the Company’s ability to devise and execute strategies to respond to market conditions.

CONTACT:
CONMED Corporation
Robert Shallish
Chief Financial Officer
315-624-3206

FD
Investors:
Brian Ritchie
212-850-5600

Filed Under: Healthcare Business, Hospitals and Health Systems

Banyan Corporation’s "America’s Dentist" Division Enters Agreement With Nationally Renowned Dental Consultant for Dental Group Development

Posted on September 7, 2010 Written by Editor

SOURCE: Banyan Corporation

BOCA RATON, FL–(Marketwire – September 7, 2010) –  Banyan Corporation (PINKSHEETS: BNYN) announced that it has reached an agreement with Mark Eric Bailey to partner with it in the development of its America’s Dentist concept. When operational, America’s Dentist will offer a vast array of services to dental practices nationwide, including marketing; real estate/leasing support; practice management and analysis; finance; branding; practice purchase and sale representation and practice transitions.

Mark Eric Bailey has served general & specialty dentists nationwide regarding practice finance & advice at Capital4HealthCare, LLC. In 2005, he founded Dentcetera Dental Practice Advisors, LLC which provides advice, analysis and buyers representation for general & specialty dentists and in 2007 he co-founded edentalspace.com, the first global social networking site exclusively for dental professionals. Mr. Bailey has completed 463 dental practice transitions in his career. Dentcetera services will be rebranded Americas Dentist and will feature buyer’s representation or traditional practice brokerage services.

Mr. Bailey stated, “I am excited by this opportunity to participate with Banyan Corporation in the development of America’s Dentist. In today’s economy, it is more important than ever before for a dental practice to operate at its optimum, not just clinically but as a business. At America’s Dentist we will feature state-of-the-art practice management software to analyze the present business performance of a practice, and our consulting team will be able to quickly assess and recommend decisions to immediately increase a practice’s performance. Whether our services lead to the dentist’s long-term improved practice performance or help the dentist enhance practice performance in preparation for merger or acquisition, America’s Dentist services will be invaluable.”

The multi-billion dollar dental industry is the most organized of healthcare professions. Banyan Corporation believes it can leverage of the significant experience of both Mr. Bailey and its past ventures to move successfully into the dental arena.

About Banyan Corporation:

Banyan Corporation is a publicly traded holding company focused on investing in and building a network of operating subsidiaries engaged in various innovative businesses. Currently the company’s subsidiaries, Premier Medical Group, Inc. and affiliated companies, provide diagnostic testing services to physicians nationwide.

This Press Release contains or incorporates by reference forward looking statements including certain information with respect to plans and strategies of Banyan Corporation. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words “believes,” “suggests,” “anticipates,” “plans,” “expects,” and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Banyan Corporation operations that could differ materially from those indicated by such forward looking statements.

Contact:
Investor Relations
Michael Gelmon
1-310-909-4607
www.PMGtesting.com

Filed Under: Healthcare Business

American Physicians Service Group, Inc. Announces Early Redemption of All Preferred Stock

Posted on September 3, 2010 Written by Editor

SOURCE: American Physicians Service Group, Inc.

AUSTIN, TX–(Marketwire – September 3, 2010) –  American Physicians Service Group, Inc. (“APS”) (NASDAQ: AMPH) today announced that its Board of Directors had authorized the early redemption of all of APS’ 3% Series A redeemable preferred stock, valued at approximately $6 million, and payment of accrued dividends on the preferred stock through the redemption date.

Mr. Ken Shifrin, Chairman of the Board, said, “This stock was issued in 2007 in payment of refundable surplus deposits provided by our insured doctors three decades ago when our forerunner, American Physicians Insurance Exchange (“APIE”), came into existence. It is very gratifying to satisfy this obligation to those early pioneers who were believers in the doctor-owned insurance concept.”

These distributions will be made on September 24, 2010 to shareholders of record on September 3, 2010.

APS is an insurance services firm with subsidiaries and affiliates which provide medical malpractice insurance and related services for physicians and other healthcare providers. APS is headquartered in Austin, Texas.

This press release includes forward-looking statements related to APS that involve risks and uncertainties that could cause actual results to differ materially. These forward-looking statements are made in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. For further information about these factors that could affect the future results of APS, please see the recent filings with the Securities and Exchange Commission. Prospective investors are cautioned that forward-looking statements are not guarantees of future performance. Actual results may differ materially from management expectations. Copies of the filings are available upon request to APS.

For further information, please visit the website of APS at www.amph.com or contact the following:
Mr. Kenneth Shifrin
Chairman of the Board (or)
Mr. Tim LaFrey
President (or)
Mr. Marc Zimmermann
Chief Financial Officer
American Physicians Service Group, Inc.
1301 S. Capital of Texas Highway, Suite C-300
Austin, Texas 78746
(512) 328-0888

Filed Under: Healthcare Business, Hospitals and Health Systems

Virtual Pharma Rep(TM) Partners With digitalDVM(TM) to Launch virtualVetRep(TM) for the Animal Health Industry

Posted on September 2, 2010 Written by Editor

SOURCE: Virtual Pharma Rep

Virtual Pharma RepTM E-Detailing Platform Brings a New Virtual Sales Approach to the Animal Health Industry

OAK BROOK, IL–(Marketwire – September 2, 2010) –  Virtual Pharma Rep™, a leader in e-detailing marketing strategies, announced today that the company has entered into an agreement to provide their patent-pending e-detailing platform for use as the foundation for a new progressive communication program, in partnership with digitalDVM™, a sales and marketing solutions provider for the animal health industry.

Virtual Pharma Rep™ facilitates a paradigm shift in the traditional sales process, and revolutionizes expensive sales models with a fresh, value-added approach that supplements existing field reps and provides a new voice in the sales process. The partnership between Virtual Pharma Rep™ and digitalDVM™ brings together key components that supplement and enhance existing sales and marketing strategies for the animal health industry. Timely, relevant product and support information will be provided to busy veterinarians in an appealing format that meets the needs of the growing number of practices who prefer online resources that can be accessed at their convenience. 

“Virtual Pharma Rep™ has had significant success in the pharmaceutical industry,” said Jim Rediehs, CEO of Virtual Pharma Rep™. “The versatility of our e-detailing platform allows us to branch into new markets like Animal Health. It shares many similarities with the pharmaceutical market, and VPR provides a tool we know will prove useful for sales reps and veterinarians to maximize time, enhance education and therefore better serve their clients within the animal health industry.”

“More than 80% of physicians participate in e-detailing from pharmaceutical companies, and with the explosive growth of internet use among veterinary professionals, now is the time to make this service available to those in the animal health industry,” said Daryl Schraad, president of digitalDVM™. “virtualVetRep™ complements existing sales and marketing efforts by adding increased voice to top veterinary targets, and provides a cost-effective alternative to increasing field representatives in remote geographical regions.”

digitalDVM™’s virtualVetRep™ offers customized one-on-one virtual sales calls that include streaming video messages, live chat and sample or literature requests. In addition, the service connects veterinarians directly with their field sales representative, which helps optimize field sales call cycles and clinic staff’s time.

The virtualVetRep™ service is available to animal health product manufacturers and distributors worldwide.

About Virtual Pharma Rep™

Virtual Pharma Rep™ is revolutionizing the pharmaceutical industry by leading the paradigm shift to virtual sales support and service models that enhance or replace existing and expensive pharmaceutical marketing strategies. Led by a team that is highly experienced in the creation of future sales and growth strategies in pharmaceuticals, Virtual Pharma Rep™‘s patent pending sales platform shares a cost reduction within the pharmaceutical industry by streamlining existing sales and marketing strategies. In addition, thanks to VPR’s disease awareness, management and compliance processes, VPR assists with overall long-term healthcare cost reductions in the form of fewer doctor’s office visits and hospitalizations. For more information please visit www.virtualpharmarep.com.

About digitalDVM™
With a growing portfolio of advanced technology and innovative marketing platforms, digitalDVM™ enables animal health companies to gain more effective, immediate access to progressive veterinarians. Best-in-class capabilities include virtualVetRep™, an exclusive e-detailing platform for product and service information, groupDVM™ ecommerce solutions, and virtualRepCoach™, the digital alternative for sales representative training and development. Based in Denver with a worldwide clientele, the company works directly with product manufacturers and distributors throughout the animal health industry. More information is available at www.digitaldvm.com.

Media Contact:
Ann Norman
+1-310-927-5158
Email Contact

Filed Under: Healthcare Business, Prescription Drugs and Pharmacy

Metiscan Discusses Revolutionary Technologies for $80B Convention, Trade Show and Meeting Industry, Digital Medical Information, Financial Highlights…

Posted on September 2, 2010 Written by Editor

SOURCE: Metiscan, Inc.

DALLAS, TX–(Marketwire – September 2, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) announced today shareholder points of interest discussed during the Company’s nationwide teleconference yesterday. Mr. Bryan A. Scott, President & CEO, and Mr. Brian Hart, COO of Metiscan, provided deeper insight into its subsidiaries’ markets, products, and near term objectives, as well as Metiscan’s pursuit in listing on the OTCBB.

During the Teleconference, Mr. Scott detailed Metiscan’s corporate structure as the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing growing its subsidiary Taptopia through technologies that are unique to its products and through acquisitions that complement its subsidiaries’ operations. Metiscan’s four subsidiaries are FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc. and Shoreline Employment Services, Inc. Mr. Scott further discussed Metiscan’s recent filing of its registration statement and its goal to meet the OTC Market requirements to qualify for the OTCBB market tier.

Mr. Scott also mentioned how Taptopia was founded in July 2009 with the vision of applying new technologies to the $80 Billion convention, trade show and meeting industry that revolutionize the way show managers and event organizers do business. Mr. Scott stated that, “the industry is greatly in need of technologies, more specifically software technologies, that aid exhibitors and attendees to realize more value from their events, as well as aid show managers with tools that help increase attendance and reduce costs.” He also summarized that Taptopia’s goal is to create and roll out new patent protect software technologies, which Taptopia has in its pipeline.

Bryan Hart, COO of Metiscan, mentioned that the Company is trending in a positive manner. Mr. Hart explained how Metiscan realized approximately $2.5M in revenues for year-end 2009, a 144% increase from year-end 2008. During 2010, the Company’s revenues have continued to increase over the last two quarters. Mr. Hart stated, “This quarter alone we experienced a 47% increase in our revenues, or $165,439 from the same period in 2009.” Mr. Hart also mentioned that during the first half of 2010 Metiscan experienced a 16% increase in its revenues, a $194,111 gain. The Company’s overall revenues as of June 30, 2010 were $1,413,490.

Mr. Hart stressed the importance of how digital medical information, specifically the electronic healthcare record systems FirstView administers and Schuylkill Open MRI recently implemented, saves the medical industry time and money. He stated that, “Metiscan strongly believes that storing medical information digitally, and being able to distribute it electronically, is a great cost savings by itself.” Mr. Hart also mentioned that last year $19 billion in the stimulus package targeted physicians to use electronic health record systems because EHR technology cuts costs, eliminates paperwork and helps doctors deliver high quality, coordinated care to patients. Mr. Hart explained that this will benefit Metiscan both for its imaging center as it relates to the benefit of the operational efficiencies EHR provides, and for FirstView as it relates to the professional Healthcare IT services it provides.

Mr. Hart explained how Metiscan demonstrated positive income from operations during the first half of 2010 totaling $184,464. Mr. Hart mentioned that Metiscan has constantly been focused on increasing operational efficiencies in all of its subsidiaries. Mr. Hart gave the example of how Schuylkill Open MRI moved towards more economical service contracts for maintaining all of its MRI equipment in its diagnostic imaging center and recently implemented a new EHR system. With FirstView, Mr. Hart said it reduced costs related to operating its data center and the amount of personnel needed for its billing and collection activities. He summarized his discussion on Metiscan’s subsidiaries, pointing out that Shoreline, its employment services division, has focused on economies of scale as it relates to personnel resources and benefits.

In closing, Mr. Scott stated, “We are very excited about our business activities here at Metiscan. We have great expectations for our company and our team believes in its future. We have been successful in building a company that is displaying both financial growth and innovation in new products and technologies.”

A recording of Metiscan’s nationwide teleconference will be available on the Company’s website at: www.metiscan.com within the next few days.

About Metiscan, Inc.

Metiscan, Inc. (Metiscan) (PINKSHEETS: MTIZ) is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Contact:

Investor Relations
1 407-389-5900
Email Contact

Filed Under: Healthcare Business

MEDIA ADVISORY/PHOTO OP: Brite Studios’ Grand Opening Brings Sought After Childcare Services to Expanding Calgary Community

Posted on September 1, 2010 Written by Editor

CALGARY, ALBERTA–(Marketwire – Sept. 1, 2010) –

WHAT: Next Wednesday, September 8, marks the grand opening of Brite Studios’ (Brite’s) new location. Brite Studios, formerly known as Calgary Children’s Centre, is Calgary’s premier childcare and recreational facility. At their launch event, Brite will demonstrate how they are working to improve the quality and amount of childcare services in our ever-growing city. 

As part of the event, there will be a creative ribbon-cutting ceremony as well as a brief performance by some of the children who attend Brite Studios. There will also be interactive artwork involving the attendees. The Honourable Ron Liepert and Alderman Joe Connelly will be in attendance to show their support. They will be addressing the audience with a few words on the importance of Brite Studios.

Representatives of Brite Studios, local and provincial government and academics will be gathering to celebrate the new name and location of this important centre for child learning and recreation.

WHO: In attendance will be:

Alberta Energy Minister Ron Liepert

Alderman Joe Connelly

Lisa Davis, Founder and CEO of Brite Studios

WHEN: Wednesday, September 8, 2010 

10:00 a.m. 

*Media are requested to arrive at 9:45 a.m. sharp.

WHERE: 

Brite Studios

Unit 148, 30 Springborough Blvd SW

Calgary, AB T3H 0N9

*Photo opportunities are available.

*Click here for map.

Filed Under: Healthcare Business

Metiscan Nationwide Teleconference Today

Posted on September 1, 2010 Written by Editor

SOURCE: Metiscan, Inc.

Company to Discuss Shareholder Points of Interest

DALLAS, TX–(Marketwire – September 1, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) is pleased to announce that the Company will be hosting a Nationwide Teleconference today, Wednesday, September 1, 2010 at 4:15 PM (Eastern Daylight Time) to update the financial community on points of interest that affect Metiscan and its shareholders. The Company will be discussing its recent operational accomplishments that have transpired over the previous six months as well as providing insight into objectives Metiscan has outlined for the near term.

If you would like to participate in the Nationwide Teleconference with Metiscan at 4:15 PM EDT today, please dial 1-800-871-9060, pass code 943301958#.

“This teleconference is very timely for Metiscan; we have accomplished many goals during the last six months that we want to share with the investment community and we look forward to discussing what’s next for the Company in a public forum,” stated Bryan A. Scott, CEO & President of Metiscan, Inc.

The Nationwide Teleconference will be hosted and moderated by Marc Jablon, CEO of Big Apple Consulting USA. The featured speakers for Metiscan, Inc. will be Bryan A. Scott, President, CEO & Director, and Brian Hart, COO.

About Metiscan, Inc.
Metiscan, Inc. (Metiscan), (PINKSHEETS: MTIZ), is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Contact:
Investor Relations
1 407-389-5900
Email Contact

Filed Under: Healthcare Business

Ossur Forms Strategic Alliance With Hely & Weber

Posted on September 1, 2010 Written by Editor

SOURCE: Ossur Americas

New Partnership Gives Ossur Customers More Choices in High-Quality Orthopaedic Soft Goods

FOOTHILL RANCH, CA–(Marketwire – September 1, 2010) –  Össur, a global leader in non-invasive orthopaedics, today announced a new strategic alliance with Hely & Weber, a supplier of innovative, high-quality braces and supports. Founded in 1992, founders John Hely and Jim Weber have a combined 76 years of experience in the orthopedic and sports medicine industry. The Hely & Weber line includes renowned products such as the Titan Wrist Brace, Shields Patella Stabilizer, Knapp Hinged Knee, and 24 patented soft bracing products which have a long history of successful clinical performance.

Beginning September 1, Össur will participate in an agreement to distribute Hely & Weber’s line of soft goods through Össur’s Group Purchasing Organization (GPO) contracts. Hely & Weber’s line will also be available through three of Össur’s representatives: Team Makena (So.CA), Synergy Orthopedics (East PA, NJ), and Dashe Orthopedic Supplies (TX, AR, OK).

“We welcome the opportunity to provide Hely & Weber’s high-quality products to our customers,” said Mahesh Mansukhani, Össur Americas president. “The addition of Hely & Weber products to our line expands our ability to provide innovative products that drive successful patient outcomes for our customers.”

John Hely, CEO of Hely & Weber, commented, “We are excited about the opportunity to work with Össur to strengthen our market presence. Össur is a leading company that is well positioned to continue its success in the non-invasive orthopaedic area.”

About Össur

Össur (NASDAQ/OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people’s mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapies. A recognized “Technology Pioneer,” Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. Össur Americas’ headquarters are based in Orange County, CA.

Contacts
Ossur Americas:
Mary Nash
Director of Marketing Communications
(949) 382-3844
[email protected]

Click here to see all recent news from this company

Filed Under: Healthcare Business

MyMedicalRecords Sponsors Hallmark Channel’s "The Spirit of Mississippi" and Clear Channel Network Radio Launch of Personal Health Records

Posted on September 1, 2010 Written by Editor

SOURCE: MMRGlobal, Inc.

LOS ANGELES, CA–(Marketwire – September 1, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF) (www.mmrglobal.com) expands its advertising of Personal Health Records products and services (www.mymedicalrecords.com) on national television tonight, September 1, 2010, at 6 pm EDT, in “The Spirit of Mississippi,” on the Hallmark Channel. The Company also announced that starting today, a nationwide radio Listener Loyalty Program was launched with Clear Channel Communications in which listeners will be directed to MMR’s website to take advantage of the Company’s end of Summer Labor Day promotion of a 30-day trial and $25 toward the cost of their next doctor visit (www.mmrvideos.com).

Robert H. Lorsch, Chairman and Chief Executive Officer of MMRGlobal, said, “Labor Day weekend was chosen to launch this radio marketing campaign because it is a great time to reach consumers about the importance of having a Personal Health Record when traveling with the family.”

Lorsch continued, “The people of Mississippi and the entire Gulf region are making progress in rebuilding their lives. Our products offer the reliability and resiliency needed to recover more quickly from any emergency or disaster. With MyMedicalRecords, individuals and families can have direct access to their most important documents, including insurance policies, deeds of trust, wills, birth certificates and advance directives, in addition to their medical records. Everything is located in one secure, convenient location accessible from any Internet connection anywhere in the world.”

About Clear Channel Communications, Inc.

Founded in 1972, with headquarters in San Antonio, TX, the Company broadcasts in over 50 countries through its divisions, Clear Channel Radio: San Antonio, TX and Clear Channel Outdoor: San Antonio, TX and reaches more than 154 million people, or 75% of the 18+ U.S. population, operating over 800 radio stations reaching more than 97 million listeners every week. With international partners, the Company owns and operates more than 140 radio stations in Australia and New Zealand. Premiere Radio Networks syndicates 90 radio programs and services to more than 5,000 radio stations affiliations reaching over 190 million listeners a week.

About MMRGlobal, Inc.

MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward-Looking Statements. Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.’s business prospects, results of operations or financial condition, government regulation, television programming changes, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

Contact:

Michael Selsman
Public Communications Co.
(310) 553-5732
[email protected]

Bobbie Volman
MMRGlobal, Inc.
(310) 476-7002, Ext. 2005
[email protected]

Click here to see all recent news from this company

Filed Under: Healthcare Business

Metiscan Nationwide Teleconference Set for Tomorrow

Posted on August 31, 2010 Written by Editor

SOURCE: Metiscan, Inc

Company to Discuss Shareholder Points of Interest

DALLAS, TX–(Marketwire – August 31, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ) is pleased to announce that the Company will be hosting a nationwide teleconference on Wednesday, September 1, 2010 at 4:15 PM (Eastern Daylight Time) and will discuss points of interest that affect Metiscan and its shareholders. The Company will be discussing its recent operational accomplishments that have transpired over the previous six months as well as providing insight into objectives Metiscan has outlined for the near term.

The nationwide teleconference will be hosted and moderated by Marc Jablon, CEO of Big Apple Consulting USA. The featured speakers for Metiscan will be Bryan Scott, President, CEO & Director, Janine Frieh, CFO & Director, and Brian Hart, COO & Director.

Space is limited on the call-in lines, therefore in order to participate please call 407-389-5900 and ask for investor relations to make a reservation. If you have a particular question for Mr. Scott, Ms. Frieh or Mr. Hart, please email questions in advance to [email protected].

About Metiscan, Inc.

Metiscan, Inc. (Metiscan), (PINKSHEETS: MTIZ), is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Contact:

Investor Relations
1 407-389-5900
Email Contact

Filed Under: Healthcare Business

Youth Invited to Audition for Recovery Acres Society’s presentation of Moscow Ballet’s SWAN LAKE

Posted on August 31, 2010 Written by Editor

CALGARY, ALBERTA–(Marketwire – Aug. 31, 2010) – This Saturday, Recovery Acres (Calgary) Society and Moscow Ballet will host open auditions for Swan Lake on Saturday, September 4, 9:00AM at Ballet Classique, 176 Bedford Drive NE. The accepted applicants will perform on November 22 & 23 in Moscow Ballet’s Great Russian Swan Lake at 7:30PM, at the EPCOR CENTRE’S Jack Singer Concert Hall.

Swan Lake auditions are for pre-professional ballet students, ages thirteen to sixteen with pointe experience. Twelve applicants will be chosen to dance in one scene of Swan Lake with the 40-strong professional, Russian trained cast. Applicants must dress in dance attire and be prepared to dance en pointe. For local information, contact Sara Lynne Dewer at (403) 245 4346.

Nataliya Miroshnyk, a Russian trained soloist with Moscow Ballet, will conduct the audition and work with the selected students in rehearsal at a later date. During her audition tour, she will work one-on-one with young dancers in Calgary, Medicine Hat, Regina, Saskatoon, Surrey, Winnipeg and Thunder Bay. Nataliya, a graduate from the well-respected Kiev Academic Choreographic School in Ukraine, trained under the honoured A.G. Kalchenko.

“Having Nataliya lead auditions is both exciting and inspirational,” says Sara Lynne Dewer, Ballet Classique’s director. “Not only does she expose dancers to authentic Russian form, but this opportunity epitomizes inclusive artistic collaboration – providing a flavour of local, amateur energy in this production, is a true gift for these children, and for audiences.”

The Moscow Ballet Canadian tour is presented by Recovery Acres (Calgary) Society, one of Canada’s most effective, non-profit, addiction treatment facilities. A portion of tour proceeds will support capital funding for the facility’s needed $10M expansion project.

As one of the most revered ballets in the world, Swan Lake premiered over a century ago in Russia and remains a timeless classic, expressing a range of human emotions accented by Tchaikovsky’s luminous score.

Ticket prices range from $45-$140 and are now available through www.epcorcentre.org.

To view promotional reel, please visit: Great Russian Swan Lake.

For more information on the Moscow Ballet Canadian Tour, please visit www.moscowballetcanada.com.

About Nataliya Miroshnyk – Visiting Ballet Mistress

Nataliya enjoyed a tremendous amount of post-graduate experience throughout the world during her time with the Odessa State Academic Opera and Ballet Theatre. She was with the Company for almost twelve years and traveled to many countries including China, Japan, Germany, Lebanon and Finland. 

Nataliya also worked with La Classique, a well-known classical ballet troupe based in Moscow. Working with La Classique gave her the opportunity to perform in front of new audiences throughout the United Kingdom, Italy and Norway.

About Moscow Ballet – The Company

Moscow Ballet (est. 1993) is a Massachusetts-based touring company, whose roster features graduates of Perm, Yaganova, Moscow State Academic Choreographic and Kiev schools from Russia each year. Created by award-winning theatrical producer and Juilliard alumni, Akiva Talmi, the company tours upwards of 70 US cities per year, recently branching into a growing number of Canadian cities.

Through the Moscow Ballet’s Educational Outreach Program, “Celebrating Children: The Arts Can Make a Difference”, the company engages local children to audition and appear with professional dancers in the roles of cygnets, snowflakes and butterflies. www.nutcracker.com.

About Recovery Acres (Calgary) Society – Tour presenter & beneficiary

In partnership with the Moscow Ballet, Calgary-based Recovery Acres Society is raising $10 million dollars of capital funding to build a new alcohol and drug treatment facility for men. Once complete, the current building will be renovated to accommodate female clients. Wait lists are ever growing and the need, particularly for woman, is consistently on the rise.

Recovery Acres (Calgary) Society is a North American leader in the treatment of alcohol and drug addiction. Their proven Recovery Model serves as a best practices model for treatment facilities and clients from around the world. The affordability of its program opens the reality of rehabilitation to a broad spectrum of clientele. www.recoveryacres.org.

Filed Under: Healthcare Business

Extendicare REIT Announces Appointment to Board of Trustees

Posted on August 30, 2010 Written by Editor

MARKHAM, ONTARIO–(Marketwire – Aug. 30, 2010) – Extendicare Real Estate Investment Trust (“Extendicare REIT” or the “REIT”) (TSX:EXE.UN) today announced the appointment of Margery Cunningham, CFA, to its Board of Trustees, effective immediately, for a term to expire at the next annual meeting of unitholders, whereupon Ms. Cunningham will stand for election.

Margery Cunningham brings with her invaluable experience as a highly regarded analyst within the health care sector. Ms. Cunningham was with Lehman Brothers for 11 years beginning in 1997, most recently as Managing Director and Global Head of Product Training, overseeing training for over 28,000 employees. Prior positions with Lehman Bothers included, Associate Director of Credit Research, responsible for managing, training and developing new analysts and associates in the Fixed Income Credit Research Department, and as a High Yield Bond Analyst. As an analyst, Ms. Cunningham was a perennial Institutional Investor magazine all-star analyst in the high yield health care category. Her research career has spanned more than 20 years, including both equity and fixed income research for firms such as Kidder, Peabody & Co., and Paine Webber.

“Extendicare REIT is delighted to welcome Ms. Cunningham to its Board of Trustees,” said Mel Rhinelander, Chairman of Extendicare REIT. “Ms. Cunningham will be a valuable board member providing input and guidance as we develop strategies to position Extendicare REIT for continued success. Along with the additions earlier this year of Governor Howard Dean and Ben Hutzel, we feel we have taken important steps to add depth to our Board of Trustees.”

Ms. Cunningham received her A.B. in Applied Mathematics from Harvard University in 1980, and went on to receive an M.S. in Management with a concentration in Finance and Economics from the Sloan School of Management, Massachusetts Institute of Technology, in 1982. As well, she is a Chartered Financial Analyst.

About Us

Extendicare REIT is a leading North American provider of long-term and short-term senior care services through its network of owned and operated health care centers. We employ 37,800 qualified and experienced individuals dedicated to helping people live better through a commitment to quality service that includes post-acute care, rehabilitative therapies and home health care services. Our 263 senior care centers in North America have capacity for approximately 29,200 residents. Extendicare REIT is a specified investment flow-through trust (SIFT) that has been subject to the SIFT tax since January 1, 2007.

Forward-looking Statements

Information provided by Extendicare REIT from time to time, including this release, contains or may contain forward-looking statements concerning anticipated financial events, results, circumstances, economic performance or expectations with respect to the REIT and its subsidiaries, including its business operations, business strategy, and financial condition. Forward-looking statements can be identified because they generally contain the words “expect”, “intend”, “anticipate”, “believe”, “estimate”, “project”, “plan” or “objective” or other similar expressions or the negative thereof. Forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available, and the REIT assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the REIT to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on the REIT’s forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare REIT with the securities regulatory authorities, available at www.sedar.com and on the REIT’s website at www.extendicare.com.

Filed Under: Healthcare Business, Senior Care

PPJ Enterprise Announces Today the Most Exciting News During the Last Three Years — That It Has Reached Its Highest Revenue in August, 2010

Posted on August 27, 2010 Written by Editor

SOURCE: PPJ Enterprise

The Company Grossed Over $85,000 During the First 26 Days of August, 2010; The Company’s Estimation of Revenue for 12 to 18 Months Is on Its Way to Becoming a True Fact and the Company Expects to Finish This Month With Gross Revenue Over $90,000 to $100,000 With the Knowledge of Pending Checks on the Way

RENO, NV–(Marketwire – August 27, 2010) – PPJ Enterprise (PPJ) (PINKSHEETS: PPJE) (“The Company”), a leader in proprietary automated health care reimbursement cycle (all specialties), online health information digital systems and practice information management digital system software for health care and general businesses worldwide, has announced that its subsidiary, Professional Billing Service (PBS), has exceeded its gross revenue over $85,000 during the first 26 days in August of 2010. The Company expects to end the month with gross revenue of $90,000 to $100,000 with the knowledge of pending checks on the way.

Company’s expectation of revenue was delayed due to some unusual circumstances such as some of the large clients provided wrong Medicare PTAN (provider number), EIN number with wrong everything else and became adamant of the accuracy of the information. None of the insurance company and Medicare could recognize those clients to issue payments. Most of the issues have been resolved and checks are being issued to those clients now.

“I like to inform our shareholders that we have worked relentlessly through very difficult situations by keeping their interests in our heart and now I am very pleased to stat that we are on our way to the next level” — Noted by our CEO, Ms. Basu.

Company employees specially few of them barely got any decent payments as compensation but took a chance with the Company. Ms. Basu, our CEO, has been paid almost nothing during the last three years. She has taken a huge hit personally but never felt discouraged about this company and its abilities to rise again.

“I sincerely thank all of our shareholders who have placed their faith in us and stayed with us in our difficult days” — CEO, Ms. Basu.

The company also reports resolution of the following issues:

1. Company is in “Active” status with Nevada Secretary of State.

2. Attorney Mr. Michael Morey of Las Vegas has been retained to provide “Attorney Letter” to Pinksheets.com. Per Pinksheets.com they are good to work with Mr. Morey. Ms. Basu personally met with Mr. Morey and provided documentation of billing service, software and claims of company assets. Mr. Morey is currently working on all documents and expects to provide the required letter to Pinksheets.com within a very short period.

3. Financials have been posted. Company expects to update by 8/31/2010, 9/30/2010 and ongoing.

4. Highly experienced PR company being interviewed, company expects to keep its shareholders informed regularly as the company becomes “Current” with Pinksheets.com.

5. Highly technical and very experienced software developer has been retained to transfer our practice management, billing and electronic health record into portable touch pad technology to provide instant access to physicians of their patients data from anywhere using mobile technology.

For more information please contact: PPJ Enterprise Management at (775) 348-5735, website: http://www.ppjenterprise.com/, email: [email protected].

Forward-Looking Statements

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This press release contains or may contain forward-looking statements such as statements regarding the Company’s growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risk and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.”

Contact:

At the Company:
R. Stewart
Public Relations Dept.
PPJ Enterprise
(775) 348-5735
Fax (866)622-3215
Email: [email protected]
http://www.ppjenterprise.com

Filed Under: Healthcare Business

Corporate Profile’s CPReports.com Publishes Ray Dirks Research’s Recommendation on Cleveland BioLabs

Posted on August 27, 2010 Written by Editor

SOURCE: Corporate Profile LLC

NEW YORK, NY–(Marketwire – August 27, 2010) –  Corporate Profile’s financial website www.CPreports.com announces Ray Dirks Research’s recommendation of Cleveland BioLabs, Inc. (NASDAQ: CBLI). 

In the report, Ray expects Cleveland BioLabs’s shares to move higher based upon upcoming inflection points, with a one-year price target of $15.

About CPreports.com
CPReports.com features Gene Marcial, Ray Dirks and Goldman Small Cap Research. The website and newsletter provide readers and subscribers fresh, original, and highly informative ideas and market commentary that they won’t get anywhere else. Content is focused on what is going on in the stock market and on Wall Street, including stories about large-capitalization as well as small-cap companies, both on the long and short side.

About Corporate Profile.com
www.CorporateProfile.com is a broadcasting website where Fashion meets Finance. Merging two mainstream industries results in the unique platform for today’s hottest tips and market info.

About Ray Dirks Research
Ray Dirks came to Wall Street with Goldman, Sachs & Co. in 1963 where he was established as the leading insurance stock analyst dealing with institutional investors and high-net worth investors both in the U.S. and internationally. Ray’s research includes Healthcare Stocks and Special Situations. Ray has written two books, “The Great Wall Street Scandal” and “Heads You Win, Tails You Win,” published by McGraw-Hill and Bantam Books respectively. He continues to provide research to institutions and individuals. Ray can be reached at: [email protected] or 917-923-0487.

Safe Harbor Disclaimer
Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company’s actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company’s plans or expectation.

Filed Under: Healthcare Business, Public Health and Research

MMRGlobal Introduces Personal Health Records for Disaster Preparedness in Network Sponsorship of "The Gulf Is Back"

Posted on August 26, 2010 Written by Editor

SOURCE: MMRGlobal, Inc.

LOS ANGELES, CA–(Marketwire – August 26, 2010) – MMRGlobal, Inc. (OTCBB: MMRF) (www.mmrglobal.com) is a sponsor of The Gulf is Back,  a one-hour TV special on the CW Network airing this Friday, August 27, 2010, at 8:00 p.m. ET. The Company believes the sponsorship of the special tribute, hosted by David Hasselhoff and featuring musical performances by Lonestar, Ricky Skaggs, Taylor Hicks and Brian McKnight, will help call attention to the importance of having a MyMedicalRecords Personal Health Record account (www.mmrvideos.com) or MyEsafeDepositBox online safe (www.myesafevideos.com) in the event of a disaster or emergency at home or anywhere in the world.

Robert H. Lorsch, MMRGlobal Chairman and Chief Executive Officer, said, “We are proud to be a sponsor of Associated Television International’s network television special The Gulf is Back. People experiencing a personal or business loss need access to the important documents necessary to rebuild their lives. Our products offer the reliability and resiliency needed to recover more quickly from any emergency or disaster. With MyMedicalRecords, individuals and families can have direct access to their most important documents, including insurance policies, deeds of trust, wills, birth certificates and advance directives in addition to their medical records. Everything is located in one secure, convenient location accessible from any Internet device anywhere in the world.”

Viewers responding to the MyMedicalRecords TV spots on The Gulf is Back will be greeted with the same onscreen technology used for the Daytime Emmy Awards last June. However, in addition to fulfilling requests for information, consumers who sign up for a free trial account can participate in the MMRGlobal $25 cash refund program applied to the viewer’s next check-up or doctor visit.

MMRGlobal’s advertising campaigns can be previewed at www.mmrontv.com. 

About MMRGlobal, Inc.
MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward-Looking Statements
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.’s business prospects, results of operations or financial condition, government regulation, television programming changes, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

Contact:

Michael Selsman
Public Communications Co.
(310) 553-5732
[email protected]

Click here to see all recent news from this company

Filed Under: Healthcare Business

SOHM Reports Consecutive Record Quarters With 1,000 Percent Year-Over-Year Revenue Increase for the Second Quarter 2010

Posted on August 26, 2010 Written by Editor

SOURCE: SOHM, Inc.

Consumer Adoption of SOHM’s Private Label Generic Pharmaceutical Products Driving Unprecedented Corporate Revenue Growth

BUENA PARK, CA–(Marketwire – August 26, 2010) –  SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, today announced that it has posted a 1,000 percent year-over-year increase in revenue for the second quarter ending June 30, 2010. Due to successive record quarters and the company’s unprecedented corporate revenue growth the Company expects continued consumer adoption of its private label generic pharmaceutical products. Revenues for the three months ended June 30, 2010 increased over 1,000% to $339,545 compared to $33,599 in the second quarter of 2009. Revenue growth was fueled by expansion of current and new clients and from pilot distribution projects to full production deployments.

Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc., stated, “Our ability to generate record revenue growth and accelerated consumer adoption rates for our generic pharmaceutical products is a direct reflection of our sales and marketing team’s dedication. We continue to demonstrate our ability to penetrate and lead in our chosen emerging markets. Most significantly, SOHM has grown and matured its generic drug manufacturing operations allowing for the scalability of resources and product production necessary to support a growing worldwide customer base.”

About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters are located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For more information, please contact:
SOHM, Inc.
Investor Relations
(714) 522-6700
Email Contact

Filed Under: Healthcare Business, Prescription Drugs and Pharmacy

Proteonomix, Inc. (PROT) Plans European Investor Road Show

Posted on August 25, 2010 Written by Editor

SOURCE: Proteonomix

Michael Cohen, Chairman and CEO, to Visit Several European Cities to Discuss Company’s Growth Plan and Future Outlook With Institutional Investors

MOUNTAINSIDE, NJ–(Marketwire – August 25, 2010) –  PROTEONOMIX, INC. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors. 

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (“XGen”), a Nevis Island limited liability company. For additional details about the joint venture agreement, please refer to the August 17, 2010 press release.

“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”

About Proteonomix, Inc.:

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (“PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies. Please also visit http://www.proteonomix.com/, http://www.proteoderm.com/, http://www.otcqb.com/ and http://www.sec.gov/.

Forward-looking statements

Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. More specifically, the investment may never occur negating the agreement, product performance and/or side effects may necessitate termination of the joint venture, the implementation of the agreement may not succeed and inadequate or no business may develop causing the failure of the joint venture and there are inherent risks in foreign operations, particularly those in the Mideast. Forward-looking statements are based on estimates and opinions of management at the time statements are made.

Contact:
Donald C. Weinberger / Adam Lowensteiner
Wolfe Axelrod Weinberger Associates, LLC
(212) 370-4500

Click here to see all recent news from this company

Filed Under: Healthcare Business

Metiscan Files 2010 10-Q Releasing Financial Results & Discusses Capital Structure

Posted on August 25, 2010 Written by Editor

SOURCE: Metiscan, Inc

47% Increase in Revenues for Q2 and Positive Income From Operations for First Half of 2010

DALLAS, TX–(Marketwire – August 25, 2010) –  Metiscan, Inc. (PINKSHEETS: MTIZ), the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services, today announces results for its second quarter ending June 30, 2010. During the three months ended June 30, 2010, revenues were up 47% and cost of revenues were reduced 25% compared to the three months ended June 30, 2009. Additionally, for the first half of 2010, the Company had positive income from operations of $184,464 and would have had positive net income of approximately $140,000, if not for a one-time write-off of uncollectable notes of approximately $350,000 in the first quarter of 2010.

           
           
  3 Months Ended June 30th   6 Months Ended June 30th
Statement of Income 2010 2009   2010 2009
Revenues 514,862   349,423     1,413,490   1,219,379  
Gross Profit 374,529   168,357     1,120,571   938,165  
Total Expenses 470,979   346,200     936,107   1,196,921  
Income (Loss) from Operations (96,450 ) (177,843 )   184,464   (258,756 )
Other Income (Expenses) (37,939 ) 238,341     (393,325 ) 197,460  
Net Income (Loss) (134,389 ) 60,498     (208,861 ) (61,296 )
                   
Balance Sheet Data                  
Total Assets 12,053,693   4,517,949     12,053,693   4,517,949  
Total Liabilities (4,458,945 ) (4,610,000 )   (4,458,945 ) (4,610,000 )
Stockholders’ equity (deficit) 7,594,748   (92,051 )   7,594,748   (92,051 )
                   
                   

Interested parties may access MTIZ’s recent 10-Q from the SEC website at www.SEC.gov.

During the three months ended June 30, 2010 the Company’s revenues were $514,862 as compared to $349,423 during the three months ended June 30, 2009. This increase of $165,439, or 47%, is primarily the result of the Company’s operation of Schuylkill Open MRI, Inc. and FirstView EHR, Inc.

The Company’s cost of revenues during the three months ended June 30, 2010 were $140,333 as compared to $181,066 during the three months ended June 30, 2009. Cost of revenues as a percentage of revenues were 27% during the three months ended June 30, 2010 as compared to 52% during the three months ended June 30, 2009. This decrease of $40,733 or 25% is a result of the increased revenues with the Company’s change in operational focus.

During the six months ended June 30, 2010 the Company’s revenues were $1,413,490 as compared to $1,219,379 during the six months ended June 30, 2009, an increase of $194,111, or 16%. Additionally, for the first half of 2010, the Company demonstrated positive income from operations of $184,464 and would have had positive net income of approximately $140,000, if not for a one-time write-off of uncollectable notes of approximately $350,000 in Q1 of 2010.

Furthermore, during the second quarter ended June 30, 2010, 58,500,000 shares of common stock were issued of which 30,000,000 restricted shares were issued related to a settlement agreement, and 28,500,000 free trading shares were issued to Big Apple Equities, LLC for investor relations services. Therefore, the issuance of these shares increased the Company’s issued shares by approximately 2.5%.

As previously announced, Metiscan will be hosting a nationwide teleconference on Wednesday, September 1, 2010 at 4:15 PM (Eastern Daylight Time) to update the financial community on points of interest that affect Metiscan and its shareholders. Space is limited on the call-in lines for this national teleconference, therefore in order to participate please call 407-389-5900 and ask for investor relations to make a reservation. If you have a particular question for the Company’s officers, please email questions in advance to [email protected].

About Metiscan, Inc.

Metiscan, Inc. (Metiscan) (PINKSHEETS: MTIZ) is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law. 

Contact:

Investor Relations
Big Apple Consulting USA, Inc.
1 407-389-5900
Email Contact

Click here to see all recent news from this company

Filed Under: Healthcare Business

WCG Wins Seven Communicator Awards of Excellence for Creative Work

Posted on August 25, 2010 Written by Editor

SOURCE: WCG

SAN FRANCISCO, CA–(Marketwire – August 25, 2010) –  WCG, a global communications company offering integrated creative, interactive and marketing communications services primarily to healthcare clients, today announced it won seven Awards of Excellence from the Communicator Awards, a leading international awards program honoring creative excellence in communications. The Award of Excellence is the highest honor in the competition, given to those entries that demonstrate “best in the field.”

The Communicator Awards are judged by the International Academy of the Visual Arts, a select and invitation-only group of leading professionals representing the best in media, communications, advertising, creative and marketing. Now in its 16th year, the awards competition had more than 9,000 entries from agencies of all sizes.

“This achievement is the result of our laser focus on putting creativity at the core of all we do so that we deliver the most impactful messaging — conceptually, visually and strategically,” said WCG’s Chief Creative Officer Paulo Simas. “I believe the strong combination of creative and strategy is foundational to a company’s success because creativity is innovation. And nothing catapults an organization like true innovation.”

WCG won the following Awards of Excellence:

  • Perlegen — MammaPLUS ( logo)
  • PEAK Surgical — PlasmaBlade ( packaging)
  • Omnicell — ASHP Omnicell Apparel ( apparel)
  • Viveve — Start the Conversation ( campaign)
  • Elan — Elan Excellence ( pharmaceuticals)
  • Medtronic — The 360 Suite ( biotechnology)
  • Medtronic — Find the AAAnswers ( social responsibility)

About WCG

WCG is led by Chairman & CEO Jim Weiss, who was named to PRWeek’s Power List for 2010. The company also recently earned the distinction of North American Agency of the Year by the Holmes Report.

WCG’s mission is to create the positive future of communications by focusing on the corporate, product marketing and communications needs of the world’s leading companies.

Serving clients from offices in San Francisco, New York, Chicago, Washington, D.C., Austin and London, WCG’s seasoned professionals specialize in branding, design, digital, interactive, social and traditional marketing, corporate and product PR, media, investor and advocacy relations, clinical trial recruitment and grassroots direct-to-patient communications campaigns.

For more information, please visit www.wcgworld.com.

Contact:
Mariesa Kemble
608-850-4745

Filed Under: Healthcare Business

Scrubs & Beyond Presents Exclusive Scrubs Jackets and More

Posted on August 25, 2010 Written by Editor

SOURCE: Scrubs & Beyond

BRENTWOOD, MO–(Marketwire – August 24, 2010) –  Scrubs & Beyond is proud to introduce a new line of medical scrubs exclusive to their already amazing selection. The David After Dentist (DAD) scrubs were inspired from the video seen online of David after a visit to his dentist. This video became so popular it was nominated for a Webby Award in the category of Best Viral Video. With scrub tops, scrubs pants and a scrub jacket to choose from, you can outfit yourself with your favorite DAD scrubs.

Most of us have seen the video where David is in the back seat of his Dad’s car, completely out of it after having a tooth pulled. During the video he can be seen asking “is this real life?”, which is the saying that DAD has chosen to run with. Scrubs & Beyond has placed the DAD logo and the saying on their new line of scrubs. David After Dentist unisex cargo scrub pants are a classic fit with drawstring waist and cargo pocket with cell phone slot. DAD unisex scrub tops feature a chest pocket with a pencil slot and stethoscope loop. This top comes in sizes up to 5X. If you are looking for a top with great value and quality construction, this one is for you.

In addition to the scrub pants and scrub top, Scrubs & Beyond also has a scrub jacket featured in the DAD lineup. Featuring two patch pockets, one cell phone pocket and knit cuffs, you are sure to love this jacket. With a snap front cardigan design and round neck, this is one of the best scrub jackets you can find. The DAD scrubs are made with the kind of quality that Scrubs & Beyond demands in their products. 

The best thing about these scrubs is that they come in a variety of thirty-two colors. Chocolate, new eggplant, dandelion, Malibu blue, aloe, shocking pink and orchid are just a few of the popular colors. Whatever color you want, you are sure to find it with that many colors to choose from. Scrubs & Beyond and David After Dentist make a great pairing with this new line of scrubs. Check out for yourself just how great this combination can be by visiting www.ScrubsandBeyond.com and buying a pair today!

Corporate Contact
Karla Bakersmith
314-961-9494, ext 14
Email Contact

Click here to see all recent news from this company

Filed Under: Healthcare Business

  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • Next Page »

Search Our Site

Categories

  • Blue Cross Blue Shield
  • Health Insurance Companies
  • Health Insurance Coverage
  • Health Technology and AI
  • Healthcare Business
  • Healthcare Policy and Law
  • Hospitals and Health Systems
  • Medicaid and CHIP
  • Medicare
  • Prescription Drugs and Pharmacy
  • Public Health and Research
  • Senior Care

Entity Map

Disclaimer

All content on Health Plan News and information provided on this website is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Always consult with a healthcare professional before starting any diet, exercise, or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.

Copyright © 2026 - Privacy Policy - Terms of Use - Disclaimer